WeVote
Log In

Bill

Bill

SB 1166

Insurer Disclosures on Prescription Drug Coverage

2026 Regular Session Introduced by Ana Maria Rodriguez

Florida bill requires insurers to disclose detailed prescription drug coverage information including formularies, costs, and prior authorizations to help consumers compare plans before enrollment.

Died in Banking and Insurance
#(adopted) #subjectindex
0
WeVote Research Nonpartisan
Bill Summary · SB 1166

Legislative bill overview

SB 1166 requires health insurance companies operating in Florida to provide detailed disclosures to consumers about their prescription drug coverage, including formulary details, cost-sharing amounts, and prior authorization requirements. The bill aims to increase transparency in how insurers structure their drug benefit plans before consumers enroll or make coverage decisions.

Why is this important

Prescription drug costs represent a significant portion of healthcare expenses for many Floridians, yet coverage details are often difficult to understand or compare across plans. Better disclosure requirements can help consumers make informed coverage choices and identify potential gaps in medication access, particularly for those with chronic conditions requiring specific drugs.

Potential points of contention

  • Compliance burden: Insurance companies may argue that expanded disclosure requirements increase administrative costs, potentially leading to higher premiums for all policyholders
  • Information complexity: Critics may contend that more detailed disclosures could overwhelm rather than help consumers, especially those with limited health literacy
  • Competitive concerns: Insurers might claim detailed formulary disclosures could disadvantage Florida-based plans compared to national competitors with less stringent requirements in other states

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.